Acromegaly: assessing the disorder and navigating therapeutic options for treatment

Endocr Pract. 2014 Oct:20 Suppl 1:7-17; quiz 18-20. doi: 10.4158/EP14430.RA.

Authors

Shlomo Melmed¹, David L Kleinberg², Vivien Bonert³, Maria Fleseriu⁴

Affiliations

¹ Dean of the Medical Faculty, Helene A. and Philip E. Hixon Chair in Investigative Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
² Department of Medicine, NYU Langone Medical Center, New York, New York.
³ Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA.
⁴ Medicine, (Endocrinology) and Neurological Surgery, Director Northwest Pituitary Center, Oregon Health & Science University, Portland, OR.

PMID: 25374336
DOI: 10.4158/EP14430.RA

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Acromegaly / diagnosis*
Acromegaly / epidemiology
Acromegaly / etiology
Acromegaly / therapy
Combined Modality Therapy
Comorbidity
Early Diagnosis
Education, Medical, Continuing
Evidence-Based Medicine*
Human Growth Hormone / metabolism*
Humans
Models, Biological*
Pituitary Gland / metabolism*
Practice Guidelines as Topic
Precision Medicine*
Prognosis
Quality of Life*

Substances

Human Growth Hormone